Chiong, Edmund <br/><br/>
NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guérin therapy for bladder cancer.  [electronic resource] 

 -  European urology  Mar 2011 
 - 430-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-7560 
<br/><br/><label>Standard No.: </label>10.1016/j.eururo.2010.11.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravesical<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>BCG Vaccine--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Cation Transport Proteins--genetics<br/>Female<br/>Follow-Up Studies<br/>Glutathione Peroxidase--genetics<br/>Humans<br/>Immunologic Factors--administration & dosage<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--genetics<br/>Polymorphism, Restriction Fragment Length<br/>Predictive Value of Tests<br/>Prognosis<br/>Promoter Regions, Genetic--genetics<br/>Treatment Outcome<br/>Urinary Bladder Neoplasms--drug therapy<br/>Glutathione Peroxidase GPX1